Buy Arcus Biosciences Stock | RCUS Stock Price & Latest News | Public
RCUS

Arcus Biosciences

$0.00 (0.00%)Today

    About RCUS

    Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founde...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.28
    -0.13
    -0.53
    -0.93
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $0.28

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,14B
    Volume20,26k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$37.41
    1 Year Low$7.19
    Open$17.62
    High$17.79
    Low$17.13

    Buy any stock with any amount of money.

    Download the App
    Download the app